EUVIMEDEUVIMED entdecken
Crossref

Combining ERK and autophagy inhibition has limited response in metastatic pancreatic adenocarcinoma

Michael Sestito, Brian A. Boone

Annals of Pancreatic Cancer · 2026-11 · 9 · 32-32

DOI: 10.21037/apc-26-0032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Pancreatic Cancer, 2026-11. Verfasst von Michael Sestito und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Sestito, M., & Boone, B. A. (2026). Combining ERK and autophagy inhibition has limited response in metastatic pancreatic adenocarcinoma. Annals of Pancreatic Cancer, 9, 32-32. https://doi.org/10.21037/apc-26-0032

Vancouver

Sestito M, Boone BA. Combining ERK and autophagy inhibition has limited response in metastatic pancreatic adenocarcinoma. Annals of Pancreatic Cancer. 2026;9:32-32. doi:10.21037/apc-26-0032

BibTeX
@article{Sestito2026,
  author = {Sestito, Michael and Boone, Brian A.},
  title = {Combining ERK and autophagy inhibition has limited response in metastatic pancreatic adenocarcinoma},
  journal = {Annals of Pancreatic Cancer},
  year = {2026},
  volume = {9},
  pages = {32--32},
  doi = {10.21037/apc-26-0032}
}
Kostenlos starten →